nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—Dacarbazine—muscle cancer	0.191	0.263	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—muscle cancer	0.111	0.152	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—muscle cancer	0.0936	0.129	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—muscle cancer	0.0839	0.115	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—muscle cancer	0.0542	0.0745	CbGbCtD
Fluphenazine—ABCB1—Vincristine—muscle cancer	0.0517	0.0711	CbGbCtD
Fluphenazine—ABCB1—Etoposide—muscle cancer	0.0474	0.0652	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—muscle cancer	0.0323	0.0444	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—muscle cancer	0.0313	0.043	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—muscle cancer	0.0304	0.0419	CbGbCtD
Fluphenazine—HTR2A—hindlimb—muscle cancer	0.0041	0.0562	CbGeAlD
Fluphenazine—Pigmentation disorder—Etoposide—muscle cancer	0.00408	0.0469	CcSEcCtD
Fluphenazine—Ileus paralytic—Vincristine—muscle cancer	0.00389	0.0447	CcSEcCtD
Fluphenazine—HTR2A—appendage—muscle cancer	0.00351	0.0482	CbGeAlD
Fluphenazine—Throat tightness—Etoposide—muscle cancer	0.00278	0.0319	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—muscle cancer	0.00247	0.0284	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—muscle cancer	0.00247	0.0284	CcSEcCtD
Fluphenazine—DRD3—head—muscle cancer	0.00212	0.029	CbGeAlD
Fluphenazine—Pigmentation disorder—Doxorubicin—muscle cancer	0.00212	0.0243	CcSEcCtD
Fluphenazine—HTR6—head—muscle cancer	0.00204	0.0279	CbGeAlD
Fluphenazine—CALM3—smooth muscle tissue—muscle cancer	0.00193	0.0264	CbGeAlD
Fluphenazine—CALM2—embryo—muscle cancer	0.00192	0.0264	CbGeAlD
Fluphenazine—CALM1—embryo—muscle cancer	0.00192	0.0263	CbGeAlD
Fluphenazine—CALM3—cardiac atrium—muscle cancer	0.00166	0.0228	CbGeAlD
Fluphenazine—Appetite absent—Methotrexate—muscle cancer	0.00164	0.0189	CcSEcCtD
Fluphenazine—Urine output increased—Vincristine—muscle cancer	0.00152	0.0175	CcSEcCtD
Fluphenazine—DRD1—head—muscle cancer	0.00152	0.0208	CbGeAlD
Fluphenazine—CALM2—smooth muscle tissue—muscle cancer	0.00151	0.0207	CbGeAlD
Fluphenazine—CALM1—smooth muscle tissue—muscle cancer	0.00151	0.0206	CbGeAlD
Fluphenazine—HTR1A—renal system—muscle cancer	0.00148	0.0203	CbGeAlD
Fluphenazine—CALM2—renal system—muscle cancer	0.00146	0.02	CbGeAlD
Fluphenazine—CALM1—renal system—muscle cancer	0.00145	0.0199	CbGeAlD
Fluphenazine—CALM3—tendon—muscle cancer	0.00145	0.0198	CbGeAlD
Fluphenazine—CALM3—bone marrow—muscle cancer	0.0014	0.0192	CbGeAlD
Fluphenazine—Lethargy—Dactinomycin—muscle cancer	0.00139	0.016	CcSEcCtD
Fluphenazine—Polyuria—Vincristine—muscle cancer	0.00139	0.016	CcSEcCtD
Fluphenazine—CALM3—vagina—muscle cancer	0.00134	0.0184	CbGeAlD
Fluphenazine—CALM2—cardiac atrium—muscle cancer	0.0013	0.0179	CbGeAlD
Fluphenazine—CALM1—cardiac atrium—muscle cancer	0.0013	0.0178	CbGeAlD
Fluphenazine—CALM3—testis—muscle cancer	0.0012	0.0164	CbGeAlD
Fluphenazine—Dysphagia—Dactinomycin—muscle cancer	0.00118	0.0136	CcSEcCtD
Fluphenazine—HTR2C—head—muscle cancer	0.00118	0.0162	CbGeAlD
Fluphenazine—HTR2A—embryo—muscle cancer	0.00117	0.016	CbGeAlD
Fluphenazine—Cardiac arrest—Vincristine—muscle cancer	0.00116	0.0133	CcSEcCtD
Fluphenazine—CALM2—tendon—muscle cancer	0.00114	0.0156	CbGeAlD
Fluphenazine—CALM1—tendon—muscle cancer	0.00113	0.0155	CbGeAlD
Fluphenazine—CYP1A2—renal system—muscle cancer	0.00113	0.0155	CbGeAlD
Fluphenazine—Pancytopenia—Dactinomycin—muscle cancer	0.00112	0.0129	CcSEcCtD
Fluphenazine—CALM2—bone marrow—muscle cancer	0.0011	0.0151	CbGeAlD
Fluphenazine—HRH1—smooth muscle tissue—muscle cancer	0.0011	0.0151	CbGeAlD
Fluphenazine—CALM1—bone marrow—muscle cancer	0.0011	0.015	CbGeAlD
Fluphenazine—Pneumonia—Dactinomycin—muscle cancer	0.00106	0.0122	CcSEcCtD
Fluphenazine—CALM2—vagina—muscle cancer	0.00106	0.0145	CbGeAlD
Fluphenazine—CALM1—vagina—muscle cancer	0.00105	0.0144	CbGeAlD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—muscle cancer	0.00104	0.0119	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00102	0.0117	CcSEcCtD
Fluphenazine—CYP2E1—renal system—muscle cancer	0.00102	0.0139	CbGeAlD
Fluphenazine—Pancytopenia—Vincristine—muscle cancer	0.001	0.0115	CcSEcCtD
Fluphenazine—HTR1A—head—muscle cancer	0.000992	0.0136	CbGeAlD
Fluphenazine—Agranulocytosis—Dactinomycin—muscle cancer	0.000982	0.0113	CcSEcCtD
Fluphenazine—CALM2—head—muscle cancer	0.000975	0.0134	CbGeAlD
Fluphenazine—CALM1—head—muscle cancer	0.00097	0.0133	CbGeAlD
Fluphenazine—Photosensitivity reaction—Vincristine—muscle cancer	0.000962	0.0111	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—muscle cancer	0.000954	0.011	CcSEcCtD
Fluphenazine—Pneumonia—Vincristine—muscle cancer	0.000946	0.0109	CcSEcCtD
Fluphenazine—CALM2—testis—muscle cancer	0.000942	0.0129	CbGeAlD
Fluphenazine—Cardiac arrest—Etoposide—muscle cancer	0.00094	0.0108	CcSEcCtD
Fluphenazine—CALM1—testis—muscle cancer	0.000937	0.0128	CbGeAlD
Fluphenazine—ADRA2A—cardiac atrium—muscle cancer	0.00093	0.0128	CbGeAlD
Fluphenazine—HTR2A—smooth muscle tissue—muscle cancer	0.000918	0.0126	CbGeAlD
Fluphenazine—DRD2—head—muscle cancer	0.000896	0.0123	CbGeAlD
Fluphenazine—HTR2A—renal system—muscle cancer	0.000883	0.0121	CbGeAlD
Fluphenazine—DRD2—testis—muscle cancer	0.000866	0.0119	CbGeAlD
Fluphenazine—Dysphagia—Etoposide—muscle cancer	0.000854	0.00982	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—muscle cancer	0.000845	0.00972	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—muscle cancer	0.000839	0.00965	CcSEcCtD
Fluphenazine—HRH1—tendon—muscle cancer	0.000826	0.0113	CbGeAlD
Fluphenazine—Erythema—Dactinomycin—muscle cancer	0.000822	0.00946	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—muscle cancer	0.000811	0.00933	CcSEcCtD
Fluphenazine—ADRA2A—tendon—muscle cancer	0.000811	0.0111	CbGeAlD
Fluphenazine—CYP2D6—renal system—muscle cancer	0.000805	0.011	CbGeAlD
Fluphenazine—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000804	0.00924	CcSEcCtD
Fluphenazine—CYP2E1—tendon—muscle cancer	0.000793	0.0109	CbGeAlD
Fluphenazine—HRH1—vagina—muscle cancer	0.000766	0.0105	CbGeAlD
Fluphenazine—Pneumonia—Etoposide—muscle cancer	0.000766	0.00881	CcSEcCtD
Fluphenazine—ABCB1—embryo—muscle cancer	0.000765	0.0105	CbGeAlD
Fluphenazine—ADRA2A—vagina—muscle cancer	0.000752	0.0103	CbGeAlD
Fluphenazine—Dyskinesia—Doxorubicin—muscle cancer	0.000751	0.00864	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—muscle cancer	0.000737	0.00848	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—muscle cancer	0.000736	0.00847	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—muscle cancer	0.00073	0.00839	CcSEcCtD
Fluphenazine—Agranulocytosis—Etoposide—muscle cancer	0.000711	0.00817	CcSEcCtD
Fluphenazine—HRH1—head—muscle cancer	0.000708	0.0097	CbGeAlD
Fluphenazine—Hepatocellular injury—Doxorubicin—muscle cancer	0.000706	0.00812	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—muscle cancer	0.000698	0.00803	CcSEcCtD
Fluphenazine—ADRA2A—head—muscle cancer	0.000695	0.00953	CbGeAlD
Fluphenazine—HTR2A—tendon—muscle cancer	0.000689	0.00945	CbGeAlD
Fluphenazine—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000686	0.00789	CcSEcCtD
Fluphenazine—HRH1—testis—muscle cancer	0.000684	0.00937	CbGeAlD
Fluphenazine—CYP2E1—head—muscle cancer	0.00068	0.00932	CbGeAlD
Fluphenazine—Agitation—Vincristine—muscle cancer	0.000675	0.00777	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—muscle cancer	0.000674	0.00775	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—muscle cancer	0.000674	0.00775	CcSEcCtD
Fluphenazine—ADRA2A—testis—muscle cancer	0.000671	0.0092	CbGeAlD
Fluphenazine—Leukopenia—Vincristine—muscle cancer	0.000658	0.00756	CcSEcCtD
Fluphenazine—CYP2E1—testis—muscle cancer	0.000657	0.009	CbGeAlD
Fluphenazine—Renal failure acute—Methotrexate—muscle cancer	0.000641	0.00737	CcSEcCtD
Fluphenazine—HTR2A—vagina—muscle cancer	0.00064	0.00877	CbGeAlD
Fluphenazine—Hypertension—Vincristine—muscle cancer	0.000634	0.0073	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000627	0.00722	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000612	0.00703	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—muscle cancer	0.000604	0.00695	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—muscle cancer	0.0006	0.0069	CcSEcCtD
Fluphenazine—HTR2A—head—muscle cancer	0.000591	0.0081	CbGeAlD
Fluphenazine—Photosensitivity—Doxorubicin—muscle cancer	0.000584	0.00671	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—muscle cancer	0.000583	0.00671	CcSEcCtD
Fluphenazine—ABCB1—renal system—muscle cancer	0.000579	0.00793	CbGeAlD
Fluphenazine—Muscle spasms—Etoposide—muscle cancer	0.000572	0.00658	CcSEcCtD
Fluphenazine—HTR2A—testis—muscle cancer	0.000571	0.00783	CbGeAlD
Fluphenazine—Eczema—Doxorubicin—muscle cancer	0.00057	0.00656	CcSEcCtD
Fluphenazine—Hypotension—Vincristine—muscle cancer	0.00056	0.00644	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—muscle cancer	0.000555	0.00639	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000543	0.00625	CcSEcCtD
Fluphenazine—CYP2D6—head—muscle cancer	0.000538	0.00738	CbGeAlD
Fluphenazine—Leukopenia—Etoposide—muscle cancer	0.000533	0.00613	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—muscle cancer	0.00053	0.0061	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00053	0.00609	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—muscle cancer	0.000523	0.00602	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—muscle cancer	0.000521	0.006	CcSEcCtD
Fluphenazine—CYP2D6—testis—muscle cancer	0.00052	0.00713	CbGeAlD
Fluphenazine—Hypertension—Etoposide—muscle cancer	0.000514	0.00591	CcSEcCtD
Fluphenazine—Constipation—Vincristine—muscle cancer	0.000513	0.0059	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—muscle cancer	0.000512	0.00588	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—muscle cancer	0.000507	0.00583	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—muscle cancer	0.000494	0.00569	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—muscle cancer	0.000487	0.00561	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—muscle cancer	0.000486	0.00559	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—muscle cancer	0.000486	0.00559	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000475	0.00547	CcSEcCtD
Fluphenazine—Tachycardia—Etoposide—muscle cancer	0.000474	0.00545	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—muscle cancer	0.000474	0.00545	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—muscle cancer	0.000472	0.00543	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000467	0.00537	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—muscle cancer	0.000459	0.00528	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—muscle cancer	0.000456	0.00525	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—muscle cancer	0.000454	0.00522	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—muscle cancer	0.000443	0.0051	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—muscle cancer	0.000443	0.0051	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—muscle cancer	0.000442	0.00508	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—muscle cancer	0.000439	0.00504	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—muscle cancer	0.000438	0.006	CbGeAlD
Fluphenazine—Dyspnoea—Etoposide—muscle cancer	0.000433	0.00498	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—muscle cancer	0.000432	0.00497	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—muscle cancer	0.000426	0.0049	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—muscle cancer	0.000422	0.00486	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—muscle cancer	0.000421	0.00484	CcSEcCtD
Fluphenazine—ABCB1—vagina—muscle cancer	0.000419	0.00575	CbGeAlD
Fluphenazine—Constipation—Etoposide—muscle cancer	0.000415	0.00478	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000412	0.00474	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000404	0.00465	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—muscle cancer	0.000399	0.00458	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—muscle cancer	0.000397	0.00457	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—muscle cancer	0.000395	0.00454	CcSEcCtD
Fluphenazine—ABCB1—head—muscle cancer	0.000387	0.00531	CbGeAlD
Fluphenazine—Urticaria—Etoposide—muscle cancer	0.000386	0.00444	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—muscle cancer	0.000384	0.00442	CcSEcCtD
Fluphenazine—Headache—Vincristine—muscle cancer	0.000376	0.00432	CcSEcCtD
Fluphenazine—ABCB1—testis—muscle cancer	0.000374	0.00513	CbGeAlD
Fluphenazine—Agranulocytosis—Doxorubicin—muscle cancer	0.000369	0.00424	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—muscle cancer	0.000358	0.00412	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—muscle cancer	0.000356	0.0041	CcSEcCtD
Fluphenazine—Nausea—Vincristine—muscle cancer	0.000356	0.0041	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—muscle cancer	0.000349	0.00402	CcSEcCtD
Fluphenazine—Pruritus—Etoposide—muscle cancer	0.000344	0.00395	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—muscle cancer	0.000336	0.00386	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—muscle cancer	0.000319	0.00367	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—muscle cancer	0.000309	0.00355	CcSEcCtD
Fluphenazine—Headache—Etoposide—muscle cancer	0.000304	0.0035	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—muscle cancer	0.000297	0.00341	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—muscle cancer	0.000291	0.00335	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—muscle cancer	0.000291	0.00335	CcSEcCtD
Fluphenazine—Nausea—Etoposide—muscle cancer	0.000288	0.00332	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—muscle cancer	0.000284	0.00326	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—muscle cancer	0.000283	0.00325	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—muscle cancer	0.000276	0.00318	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—muscle cancer	0.000272	0.00313	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—muscle cancer	0.000266	0.00307	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—muscle cancer	0.000259	0.00298	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—muscle cancer	0.000259	0.00297	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—muscle cancer	0.000257	0.00296	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—muscle cancer	0.000253	0.00291	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000252	0.0029	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—muscle cancer	0.000246	0.00283	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—muscle cancer	0.000245	0.00281	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—muscle cancer	0.000235	0.00271	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—muscle cancer	0.000231	0.00266	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—muscle cancer	0.00023	0.00265	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—muscle cancer	0.000225	0.00258	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—muscle cancer	0.000224	0.00258	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—muscle cancer	0.000219	0.00252	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—muscle cancer	0.000215	0.00248	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—muscle cancer	0.000214	0.00247	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—muscle cancer	0.000206	0.00237	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—muscle cancer	0.0002	0.0023	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—muscle cancer	0.000199	0.00229	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—muscle cancer	0.000186	0.00213	CcSEcCtD
Fluphenazine—Headache—Methotrexate—muscle cancer	0.000182	0.0021	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—muscle cancer	0.000178	0.00205	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—muscle cancer	0.000173	0.00199	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—muscle cancer	0.000158	0.00182	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—muscle cancer	0.00015	0.00172	CcSEcCtD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000101	0.00089	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—IGF2—muscle cancer	0.000101	0.00089	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—FOXO4—muscle cancer	9.97e-05	0.000881	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—FOXO4—muscle cancer	9.97e-05	0.000881	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—CNR1—muscle cancer	9.91e-05	0.000875	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—FOXO4—muscle cancer	9.9e-05	0.000875	CbGpPWpGaD
Fluphenazine—DRD1—Circadian rythm related genes—TP53—muscle cancer	9.88e-05	0.000873	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—CNR1—muscle cancer	9.86e-05	0.000871	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—KIT—muscle cancer	9.84e-05	0.000869	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—KIT—muscle cancer	9.84e-05	0.000869	CbGpPWpGaD
Fluphenazine—DRD3—Circadian rythm related genes—TP53—muscle cancer	9.75e-05	0.000862	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—FOXO4—muscle cancer	9.58e-05	0.000846	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—FOXO4—muscle cancer	9.58e-05	0.000846	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—PTCH1—muscle cancer	9.36e-05	0.000827	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—PTCH1—muscle cancer	9.21e-05	0.000813	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—IGF2—muscle cancer	9.19e-05	0.000812	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—PTCH1—muscle cancer	9.19e-05	0.000812	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—CNR1—muscle cancer	9e-05	0.000795	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—CNR1—muscle cancer	8.95e-05	0.000791	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—IGF2—muscle cancer	8.89e-05	0.000785	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—IGF2—muscle cancer	8.89e-05	0.000785	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD34—muscle cancer	8.83e-05	0.00078	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—CNR1—muscle cancer	8.7e-05	0.000768	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—CNR1—muscle cancer	8.56e-05	0.000756	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD34—muscle cancer	8.55e-05	0.000755	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD34—muscle cancer	8.55e-05	0.000755	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—CNR1—muscle cancer	8.54e-05	0.000754	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—PTCH1—muscle cancer	8.51e-05	0.000751	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.49e-05	0.00075	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.39e-05	0.000741	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—FH—muscle cancer	8.38e-05	0.00074	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—PTCH1—muscle cancer	8.38e-05	0.00074	CbGpPWpGaD
Fluphenazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.2e-05	0.000724	CbGpPWpGaD
Fluphenazine—CALM3—Neuronal System—MDM2—muscle cancer	8.17e-05	0.000722	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.08e-05	0.000714	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—MDM2—muscle cancer	8.01e-05	0.000708	CbGpPWpGaD
Fluphenazine—CALM1—Neuronal System—MDM2—muscle cancer	7.91e-05	0.000698	CbGpPWpGaD
Fluphenazine—CALM2—Neuronal System—MDM2—muscle cancer	7.91e-05	0.000698	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CNR1—muscle cancer	7.9e-05	0.000698	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—FH—muscle cancer	7.9e-05	0.000698	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CNR1—muscle cancer	7.79e-05	0.000688	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CNR1—muscle cancer	7.77e-05	0.000687	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CNR1—muscle cancer	7.75e-05	0.000685	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—MDM2—muscle cancer	7.75e-05	0.000685	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—MDM2—muscle cancer	7.75e-05	0.000685	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	7.64e-05	0.000675	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—FOXO1—muscle cancer	7.61e-05	0.000673	CbGpPWpGaD
Fluphenazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.48e-05	0.000661	CbGpPWpGaD
Fluphenazine—DRD2—Circadian rythm related genes—TP53—muscle cancer	7.46e-05	0.000659	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	7.39e-05	0.000653	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	7.39e-05	0.000653	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—FOXO1—muscle cancer	7.37e-05	0.000651	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—FOXO1—muscle cancer	7.37e-05	0.000651	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PTCH1—muscle cancer	7.32e-05	0.000647	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—FOXO4—muscle cancer	7.31e-05	0.000646	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	7.31e-05	0.000646	CbGpPWpGaD
Fluphenazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.23e-05	0.000639	CbGpPWpGaD
Fluphenazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.23e-05	0.000639	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PTCH1—muscle cancer	7.22e-05	0.000638	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CNR1—muscle cancer	7.18e-05	0.000634	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	7.07e-05	0.000625	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	7.07e-05	0.000625	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	7.07e-05	0.000625	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—MED12—muscle cancer	6.85e-05	0.000605	CbGpPWpGaD
Fluphenazine—CALM3—Disease—ENO2—muscle cancer	6.8e-05	0.000601	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—FH—muscle cancer	6.69e-05	0.000591	CbGpPWpGaD
Fluphenazine—CALM1—Disease—ENO2—muscle cancer	6.58e-05	0.000581	CbGpPWpGaD
Fluphenazine—CALM2—Disease—ENO2—muscle cancer	6.58e-05	0.000581	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CNR1—muscle cancer	6.45e-05	0.00057	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.37e-05	0.000563	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—FOXO4—muscle cancer	6.3e-05	0.000556	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PTCH1—muscle cancer	6.3e-05	0.000556	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—MED12—muscle cancer	6.29e-05	0.000555	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PTCH1—muscle cancer	6.26e-05	0.000553	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—MED12—muscle cancer	6.25e-05	0.000552	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ENO2—muscle cancer	6.24e-05	0.000552	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CNR1—muscle cancer	6.24e-05	0.000551	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CNR1—muscle cancer	6.24e-05	0.000551	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—FOXO4—muscle cancer	6.21e-05	0.000549	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HMGA1—muscle cancer	6.18e-05	0.000546	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CNR1—muscle cancer	6.18e-05	0.000546	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CNR1—muscle cancer	6.1e-05	0.000539	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—MED12—muscle cancer	6.04e-05	0.000534	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—MED12—muscle cancer	6.04e-05	0.000534	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—FOXO4—muscle cancer	6.01e-05	0.000531	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HMGA1—muscle cancer	5.98e-05	0.000528	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HMGA1—muscle cancer	5.98e-05	0.000528	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IGF2—muscle cancer	5.87e-05	0.000519	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—FOXO4—muscle cancer	5.81e-05	0.000513	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—FOXO4—muscle cancer	5.81e-05	0.000513	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—KIT—muscle cancer	5.8e-05	0.000513	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ENO2—muscle cancer	5.73e-05	0.000506	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ENO2—muscle cancer	5.7e-05	0.000503	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—KIT—muscle cancer	5.61e-05	0.000496	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—KIT—muscle cancer	5.61e-05	0.000496	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—KIT—muscle cancer	5.57e-05	0.000492	CbGpPWpGaD
Fluphenazine—CALM3—Disease—FOXO4—muscle cancer	5.54e-05	0.00049	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTCH1—muscle cancer	5.53e-05	0.000488	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ENO2—muscle cancer	5.51e-05	0.000487	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ENO2—muscle cancer	5.51e-05	0.000487	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTCH1—muscle cancer	5.44e-05	0.000481	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTCH1—muscle cancer	5.43e-05	0.000479	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—FOXO4—muscle cancer	5.41e-05	0.000478	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—FOXO1—muscle cancer	5.4e-05	0.000477	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KIT—muscle cancer	5.39e-05	0.000476	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KIT—muscle cancer	5.39e-05	0.000476	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—FOXO4—muscle cancer	5.39e-05	0.000476	CbGpPWpGaD
Fluphenazine—CALM2—Disease—FOXO4—muscle cancer	5.36e-05	0.000474	CbGpPWpGaD
Fluphenazine—CALM1—Disease—FOXO4—muscle cancer	5.36e-05	0.000474	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CNR1—muscle cancer	5.31e-05	0.000469	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CNR1—muscle cancer	5.29e-05	0.000467	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IGF2—muscle cancer	5.05e-05	0.000446	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IGF2—muscle cancer	4.99e-05	0.00044	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	4.95e-05	0.000437	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.81e-05	0.000425	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—FOXO4—muscle cancer	4.75e-05	0.00042	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—MED12—muscle cancer	4.73e-05	0.000418	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—FOXO4—muscle cancer	4.68e-05	0.000413	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—FOXO4—muscle cancer	4.67e-05	0.000412	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CNR1—muscle cancer	4.67e-05	0.000412	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—FOXO1—muscle cancer	4.65e-05	0.000411	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CNR1—muscle cancer	4.59e-05	0.000406	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—FOXO1—muscle cancer	4.59e-05	0.000405	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CNR1—muscle cancer	4.58e-05	0.000405	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—MDM2—muscle cancer	4.57e-05	0.000404	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTCH1—muscle cancer	4.52e-05	0.000399	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—MED12—muscle cancer	4.46e-05	0.000394	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—FOXO1—muscle cancer	4.44e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—MDM2—muscle cancer	4.42e-05	0.000391	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—MDM2—muscle cancer	4.42e-05	0.000391	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—MDM2—muscle cancer	4.39e-05	0.000388	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTCH1—muscle cancer	4.37e-05	0.000386	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTCH1—muscle cancer	4.37e-05	0.000386	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IGF2—muscle cancer	4.34e-05	0.000384	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IGF2—muscle cancer	4.32e-05	0.000382	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ENO2—muscle cancer	4.32e-05	0.000381	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—FOXO1—muscle cancer	4.29e-05	0.000379	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—FOXO1—muscle cancer	4.29e-05	0.000379	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	4.26e-05	0.000376	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—MDM2—muscle cancer	4.24e-05	0.000375	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—MDM2—muscle cancer	4.24e-05	0.000375	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—VEGFA—muscle cancer	4.22e-05	0.000373	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CNR1—muscle cancer	4.18e-05	0.000369	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KIT—muscle cancer	4.12e-05	0.000364	CbGpPWpGaD
Fluphenazine—CALM3—Disease—FOXO1—muscle cancer	4.09e-05	0.000362	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ENO2—muscle cancer	4.07e-05	0.000359	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—FOXO1—muscle cancer	4e-05	0.000353	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—FOXO1—muscle cancer	3.98e-05	0.000351	CbGpPWpGaD
Fluphenazine—CALM1—Disease—FOXO1—muscle cancer	3.96e-05	0.00035	CbGpPWpGaD
Fluphenazine—CALM2—Disease—FOXO1—muscle cancer	3.96e-05	0.00035	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—FOXO4—muscle cancer	3.88e-05	0.000343	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—VEGFA—muscle cancer	3.85e-05	0.000341	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IGF2—muscle cancer	3.81e-05	0.000337	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CNR1—muscle cancer	3.81e-05	0.000337	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—MED12—muscle cancer	3.78e-05	0.000334	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—FOXO4—muscle cancer	3.76e-05	0.000332	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—FOXO4—muscle cancer	3.76e-05	0.000332	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IGF2—muscle cancer	3.75e-05	0.000332	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IGF2—muscle cancer	3.75e-05	0.000331	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—VEGFA—muscle cancer	3.73e-05	0.000329	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—VEGFA—muscle cancer	3.73e-05	0.000329	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CNR1—muscle cancer	3.69e-05	0.000326	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CNR1—muscle cancer	3.69e-05	0.000326	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KIT—muscle cancer	3.54e-05	0.000313	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—FOXO1—muscle cancer	3.51e-05	0.00031	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KIT—muscle cancer	3.5e-05	0.000309	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—FOXO1—muscle cancer	3.45e-05	0.000305	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—FOXO1—muscle cancer	3.45e-05	0.000305	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ENO2—muscle cancer	3.45e-05	0.000304	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IGF2—muscle cancer	3.41e-05	0.000302	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KIT—muscle cancer	3.38e-05	0.000299	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KIT—muscle cancer	3.27e-05	0.000289	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KIT—muscle cancer	3.27e-05	0.000289	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MDM2—muscle cancer	3.24e-05	0.000286	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—muscle cancer	3.19e-05	0.000282	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	3.14e-05	0.000278	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KIT—muscle cancer	3.12e-05	0.000276	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF2—muscle cancer	3.12e-05	0.000275	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KIT—muscle cancer	3.05e-05	0.000269	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KIT—muscle cancer	3.03e-05	0.000268	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KIT—muscle cancer	3.02e-05	0.000267	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KIT—muscle cancer	3.02e-05	0.000267	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF2—muscle cancer	3.01e-05	0.000266	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF2—muscle cancer	3.01e-05	0.000266	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—muscle cancer	2.91e-05	0.000257	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—FOXO1—muscle cancer	2.87e-05	0.000253	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—muscle cancer	2.82e-05	0.000249	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—muscle cancer	2.82e-05	0.000249	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MDM2—muscle cancer	2.79e-05	0.000247	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—FOXO1—muscle cancer	2.77e-05	0.000245	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—FOXO1—muscle cancer	2.77e-05	0.000245	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MDM2—muscle cancer	2.75e-05	0.000243	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.7e-05	0.000238	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KIT—muscle cancer	2.68e-05	0.000236	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MDM2—muscle cancer	2.66e-05	0.000235	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KIT—muscle cancer	2.63e-05	0.000233	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KIT—muscle cancer	2.63e-05	0.000232	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MDM2—muscle cancer	2.57e-05	0.000227	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MDM2—muscle cancer	2.57e-05	0.000227	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—VEGFA—muscle cancer	2.46e-05	0.000217	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MDM2—muscle cancer	2.46e-05	0.000217	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MDM2—muscle cancer	2.4e-05	0.000212	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KIT—muscle cancer	2.39e-05	0.000212	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MDM2—muscle cancer	2.39e-05	0.000211	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MDM2—muscle cancer	2.38e-05	0.00021	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MDM2—muscle cancer	2.38e-05	0.00021	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTGS2—muscle cancer	2.37e-05	0.000209	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTGS2—muscle cancer	2.29e-05	0.000202	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTGS2—muscle cancer	2.29e-05	0.000202	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KIT—muscle cancer	2.18e-05	0.000193	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—muscle cancer	2.17e-05	0.000192	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—muscle cancer	2.12e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KIT—muscle cancer	2.11e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KIT—muscle cancer	2.11e-05	0.000187	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MDM2—muscle cancer	2.11e-05	0.000186	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—muscle cancer	2.09e-05	0.000185	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MDM2—muscle cancer	2.07e-05	0.000183	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MDM2—muscle cancer	2.07e-05	0.000183	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—muscle cancer	2e-05	0.000176	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—muscle cancer	1.98e-05	0.000175	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—muscle cancer	1.92e-05	0.00017	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—muscle cancer	1.92e-05	0.00017	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MDM2—muscle cancer	1.89e-05	0.000167	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—muscle cancer	1.86e-05	0.000164	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.82e-05	0.000161	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.81e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MDM2—muscle cancer	1.72e-05	0.000152	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—muscle cancer	1.66e-05	0.000147	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—muscle cancer	1.66e-05	0.000147	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—muscle cancer	1.6e-05	0.000141	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—muscle cancer	1.6e-05	0.000141	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—muscle cancer	1.58e-05	0.00014	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—muscle cancer	1.57e-05	0.000139	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—muscle cancer	1.57e-05	0.000139	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—muscle cancer	1.5e-05	0.000133	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	1.43e-05	0.000127	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—muscle cancer	1.42e-05	0.000125	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—muscle cancer	1.38e-05	0.000122	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—muscle cancer	1.37e-05	0.000121	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—muscle cancer	1.31e-05	0.000115	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—muscle cancer	1.26e-05	0.000112	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—muscle cancer	1.26e-05	0.000112	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—muscle cancer	1.21e-05	0.000107	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—muscle cancer	1.2e-05	0.000106	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—muscle cancer	1.19e-05	0.000105	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—muscle cancer	1.19e-05	0.000105	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—muscle cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—muscle cancer	9.87e-06	8.72e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—muscle cancer	9.55e-06	8.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—muscle cancer	9.55e-06	8.44e-05	CbGpPWpGaD
